Figure 2.
The figure represents some of the membrane targets expressed in the clonal plasma cell surfable that are suitable for drug development. In brackets, antibodies targeting specific antigens are included (i.e., daratumumab: anti-CD38 monoclonal antibody). CAR T cell: chimeric antigen receptor T cell; FDA: U.S. Food and Drug Administration; EMA: European Medical Agency.